Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13

Objective To determine the availability of data on overall survival and quality of life benefits of cancer drugs approved in Europe. Design Retrospective cohort study. Setting Publicly accessible regulatory and scientific reports on cancer approvals by the European Medicines Agency (EMA) from 2009 t...

Descripción completa

Detalles Bibliográficos
Autores principales: Davis, Courtney, Naci, Huseyin, Gurpinar, Evrim, Poplavska, Elita, Pinto, Ashlyn, Aggarwal, Ajay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627352/
https://www.ncbi.nlm.nih.gov/pubmed/28978555
http://dx.doi.org/10.1136/bmj.j4530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627352/
https://www.ncbi.nlm.nih.gov/pubmed/28978555
http://dx.doi.org/10.1136/bmj.j4530

Ejemplares similares